(Q35048395)

6 August 2017

title

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate (English)

1 reference

6 August 2017

0 references

1 reference

Edward C Keystone

1

1 reference

6 August 2017

Peter C Taylor

2

1 reference

6 August 2017

Edit Drescher

3

1 reference

6 August 2017

Douglas E Schlichting

4

1 reference

6 August 2017

Scott D Beattie

5

1 reference

6 August 2017

Pierre-Yves Berclaz

6

1 reference

6 August 2017

Chin H Lee

7

1 reference

6 August 2017

Rosanne K Fidelus-Gort

8

1 reference

6 August 2017

Monica E Luchi

9

1 reference

6 August 2017

Terence P Rooney

10

1 reference

6 August 2017

William L Macias

11

1 reference

6 August 2017

Mark C Genovese

12

1 reference

6 August 2017

language of work or name

English

0 references

publication date

27 November 2014

1 reference

Annals of the Rheumatic Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

74

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

333-340

1 reference

Janus kinase inhibitors in autoimmune diseases

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

JAKs and STATs in immunity, immunodeficiency, and cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

The Disease Activity Score and the EULAR response criteria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

Jaks and STATs: biological implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4316868

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206478

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206478

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-206478

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

21 January 2018

1 reference

12 December 2020

Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity

1 reference

12 December 2020

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

1 reference

12 December 2020

Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis

1 reference

12 December 2020

10.1136/ANNRHEUMDIS-2014-206478

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference